Serum Cytokine 6, 10 and α-Tumour Necrosis Factor Levels in Alzheimer's Disease Subjects Treated with Donepezil Plus Vitamin B12

• Published in: Neurology India Vol. 73; no. 3; pp. 488 - 494
• Main Authors: Yeram, Neelam, Dalvi, Shubhangi M., Kale, Vinayak P., Patil, Vinayak W., Mankeshwar, Ranjit, Jagiasi, Kamlesh, Abichandani, Leela G.
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer - Medknow 01.05.2025; Medknow Publications & Media Pvt. Ltd
• Edition: 2
• Subjects: Aged; Aged, 80 and over; Alzheimer Disease - blood; Alzheimer Disease - drug therapy; Alzheimer's disease; Cholinesterase Inhibitors - therapeutic use; Cytokines; Cytokines - blood; Donepezil - therapeutic use; Drug Therapy, Combination; Female; Humans; Interleukin-6 - blood; Male; Middle Aged; Nootropic Agents - therapeutic use; Original Article; TNF inhibitors; Tumor Necrosis Factor-alpha - blood; Tumor necrosis factor-TNF; Vitamin B 12 - administration & dosage; Vitamin B 12 - therapeutic use; donepezil; inflammation; Alzheimer's disease; Vitamin B; Alzheimer’s disease

Background: Neuroinflammation is a key feature of Alzheimer's disease (AD) pathology. Objectives: The aim of this study was to investigate the serum levels of Cytokine 6 (Cyto-6), Cytokine 10 (Cyto-10), and alpha-tumor necrosis factor (α-TNF) in Alzheimer's disease patients and observe the...